353 related articles for article (PubMed ID: 29904919)
61. Anti-tumoral potential of MDA19 in human osteosarcoma via suppressing PI3K/Akt/mTOR signaling pathway.
Liu B; Xu L; Dai EN; Tian JX; Li JM
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30442873
[TBL] [Abstract][Full Text] [Related]
62. Arsenic sulfide induces apoptosis and autophagy through the activation of ROS/JNK and suppression of Akt/mTOR signaling pathways in osteosarcoma.
Wang G; Zhang T; Sun W; Wang H; Yin F; Wang Z; Zuo D; Sun M; Zhou Z; Lin B; Xu J; Hua Y; Li H; Cai Z
Free Radic Biol Med; 2017 May; 106():24-37. PubMed ID: 28188923
[TBL] [Abstract][Full Text] [Related]
63. Isoliquiritigenin Suppresses Osteosarcoma U2OS Cell Proliferation and Invasion by Regulating the PI3K/Akt Signalling Pathway.
Chen J; Liu C; Yang QQ; Ma RB; Ke Y; Dong F; Wu XE
Chemotherapy; 2018; 63(3):155-161. PubMed ID: 29936511
[TBL] [Abstract][Full Text] [Related]
64. TRIM59 predicts poor prognosis and promotes pancreatic cancer progression via the PI3K/AKT/mTOR-glycolysis signaling axis.
Li R; Weng L; Liu B; Zhu L; Zhang X; Tian G; Hu L; Li Q; Jiang S; Shang M
J Cell Biochem; 2020 Feb; 121(2):1986-1997. PubMed ID: 31693252
[TBL] [Abstract][Full Text] [Related]
65. lncRNA MEG3 had anti-cancer effects to suppress pancreatic cancer activity.
Gu L; Zhang J; Shi M; Zhan Q; Shen B; Peng C
Biomed Pharmacother; 2017 May; 89():1269-1276. PubMed ID: 28320094
[TBL] [Abstract][Full Text] [Related]
66. Honokiol suppresses proliferation and induces apoptosis via regulation of the miR‑21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells.
Yang J; Zou Y; Jiang D
Int J Mol Med; 2018 Apr; 41(4):1845-1854. PubMed ID: 29393336
[TBL] [Abstract][Full Text] [Related]
67. DKK3 knockdown confers negative effects on the malignant potency of head and neck squamous cell carcinoma cells via the PI3K/Akt and MAPK signaling pathways.
Katase N; Nishimatsu SI; Yamauchi A; Yamamura M; Fujita S
Int J Oncol; 2019 Mar; 54(3):1021-1032. PubMed ID: 30569110
[TBL] [Abstract][Full Text] [Related]
68. Hypoxia-inducible factor-1 promotes cancer progression through activating AKT/Cyclin D1 signaling pathway in osteosarcoma.
Zhang B; Li YL; Zhao JL; Zhen O; Yu C; Yang BH; Yu XR
Biomed Pharmacother; 2018 Sep; 105():1-9. PubMed ID: 29807229
[TBL] [Abstract][Full Text] [Related]
69. Reduced Malignancy of Super Methotrexate-resistant Osteosarcoma Cells With Dihydrofolate Reductase Amplification Despite Paradoxical Gain of Oncogenic PI3K/AKT/mTOR and c-MYC expression.
Aoki Y; Kubota Y; Masaki N; Obara K; Tome Y; Bouvet M; Nishida K; Hoffman RM
Anticancer Res; 2024 Jul; 44(7):2787-2792. PubMed ID: 38925854
[TBL] [Abstract][Full Text] [Related]
70. Adenovirus-mediated overexpression of BMP-9 inhibits human osteosarcoma cell growth and migration through downregulation of the PI3K/AKT pathway.
Li B; Yang Y; Jiang S; Ni B; Chen K; Jiang L
Int J Oncol; 2012 Nov; 41(5):1809-19. PubMed ID: 22948234
[TBL] [Abstract][Full Text] [Related]
71. STEAP2 promotes osteosarcoma progression by inducing epithelial-mesenchymal transition via the PI3K/AKT/mTOR signaling pathway and is regulated by EFEMP2.
Zhang D; Liu H; Wang W; Xu G; Yin C; Wang S
Cancer Biol Ther; 2022 Dec; 23(1):1-16. PubMed ID: 36316642
[TBL] [Abstract][Full Text] [Related]
72. Long non-coding RNA MEG3 inhibits cell growth of gliomas by targeting miR-93 and inactivating PI3K/AKT pathway.
Zhang L; Liang X; Li Y
Oncol Rep; 2017 Oct; 38(4):2408-2416. PubMed ID: 28791407
[TBL] [Abstract][Full Text] [Related]
73. Tumor suppressive effect of scavenger receptor class A member 5 overexpression in colorectal cancer by regulating PI3K/AKT/mTOR pathway.
Li Y; Peng F; Tan X; Wang J; Xu Y
Genes Genomics; 2021 Oct; 43(10):1189-1198. PubMed ID: 34417976
[TBL] [Abstract][Full Text] [Related]
74. CSN5 controls the growth of osteosarcoma via modulating the EGFR/PI3K/Akt axis.
Wan Z; Huang S; Mo F; Yao Y; Liu G; Han Z; Chen M; Zhiyun L
Exp Cell Res; 2019 Nov; 384(2):111646. PubMed ID: 31560888
[TBL] [Abstract][Full Text] [Related]
75. LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway.
Liu G; Zhao X; Zhou J; Cheng X; Ye Z; Ji Z
Cell Physiol Biochem; 2018; 48(1):371-384. PubMed ID: 30016766
[TBL] [Abstract][Full Text] [Related]
76. Cleavage stimulation factor 2 promotes malignant progression of liver hepatocellular carcinoma by activating phosphatidylinositol 3'-kinase/protein kinase B/mammalian target of rapamycin pathway.
Zhang MH; Liu J
Bioengineered; 2022 Apr; 13(4):10047-10060. PubMed ID: 35412944
[TBL] [Abstract][Full Text] [Related]
77. Long non‑coding RNA linc00239 promotes malignant behaviors and chemoresistance against doxorubicin partially via activation of the PI3K/Akt/mTOR pathway in acute myeloid leukaemia cells.
Yang Y; Dai W; Sun Y; Zhao Z
Oncol Rep; 2019 Apr; 41(4):2311-2320. PubMed ID: 30720129
[TBL] [Abstract][Full Text] [Related]
78. Knockdown of autophagy-related protein 6, Beclin-1, decreases cell growth, invasion, and metastasis and has a positive effect on chemotherapy-induced cytotoxicity in osteosarcoma cells.
Zhang W; Li Q; Song C; Lao L
Tumour Biol; 2015 Apr; 36(4):2531-9. PubMed ID: 25427639
[TBL] [Abstract][Full Text] [Related]
79. CHRDL2 promotes osteosarcoma cell proliferation and metastasis through the BMP-9/PI3K/AKT pathway.
Chen H; Pan R; Li H; Zhang W; Ren C; Lu Q; Chen H; Zhang X; Nie Y
Cell Biol Int; 2021 Mar; 45(3):623-632. PubMed ID: 33245175
[TBL] [Abstract][Full Text] [Related]
80. TGF-β is associated with poor prognosis and promotes osteosarcoma progression
Ma K; Zhang C; Li W
Cell Cycle; 2020 Sep; 19(18):2327-2339. PubMed ID: 32804027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]